[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 252 Enrolled Bill (ENR)]
S.252
One Hundred Thirteenth Congress
of the
United States of America
AT THE FIRST SESSION
Begun and held at the City of Washington on Thursday,
the third day of January, two thousand and thirteen
An Act
To reduce preterm labor and delivery and the risk of pregnancy-related
deaths and complications due to pregnancy, and to reduce infant
mortality caused by prematurity, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

d889afbeb79d142db16d768ef66e677b272500fb9e216c65e19a4fec680a1d55

The table of contents for this Act is as follows:

3f9decdc7498325c7f33d0140642155ca7ac6de539b721a94926988ea6b8d3f7

6af517bca47998fefddef8983f85641352f3832cea2a891afc4300501b2c664e

TITLE I

-PREEMIE ACT REAUTHORIZATION

4e811b980f5c82b4de55ad88f0416b1649b4c06de1811298183274083facdf0e

This title may be cited as the ``Prematurity Research Expansion and
Education for Mothers who deliver Infants Early Reauthorization Act''
or the ``PREEMIE Reauthorization Act''.

a22f382be5c9eb09b519a0e86d0fc1e37c663535956f28524fec2726d18cc78b

CONTROL AND PREVENTION.
(a) Epidemiological Studies.--Section 3 of the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early Act (42
U.S.C. 247b-4f) is amended by striking subsection (b) and inserting the
following:
``(b) Studies and Activities on Preterm Birth.--
``(1) In general.--The Secretary of Health and Human Services,
acting through the Director of the Centers for Disease Control and
Prevention, may, subject to the availability of appropriations--
``(A) conduct epidemiological studies on the clinical,
biological, social, environmental, genetic, and behavioral
factors relating to prematurity, as appropriate;
``(B) conduct activities to improve national data to
facilitate tracking the burden of preterm birth; and
``(C) continue efforts to prevent preterm birth, including
late preterm birth, through the identification of opportunities
for prevention and the assessment of the impact of such
efforts.
``(2) Report.--Not later than 2 years after the date of
enactment of the PREEMIE Reauthorization Act, and every 2 years
thereafter, the Secretary of Health and Human Services, acting
through the Director of the Centers for Disease Control and
Prevention, shall submit to the appropriate committees of Congress
reports concerning the progress and any results of studies
conducted under paragraph (1).''.
(b) Reauthorization.--Section 3(e) of the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early Act (42
U.S.C. 247b-4f(e)) is amended by striking ``$5,000,000'' and all that
follows through ``2011.'' and inserting ``$1,880,000 for each of fiscal
years 2014 through 2018.''.

2333f1266cb6d5d47022fa8121abb340f48da0452500912d2088f8d938f9691c

ADMINISTRATION.
(a) Telemedicine and High-Risk Pregnancies.--Section 330I(i)(1)(B)
of the Public Health Service Act (42 U.S.C. 254c-14(i)(1)(B)) is
amended by striking ``or case management services'' and inserting
``case management services, or prenatal care for high-risk
pregnancies'';
(b) Public and Health Care Provider Education.--Section 399Q of the
Public Health Service Act (42 U.S.C. 280g-5) is amended--
(1) in subsection (b)--
(A) in paragraph (1), by striking subparagraphs (A) through
(F) and inserting the following:
``(A) the core risk factors for preterm labor and delivery;
``(B) medically indicated deliveries before full term;
``(C) the importance of preconception and prenatal care,
including--
``(i) smoking cessation;
``(ii) weight maintenance and good nutrition, including
folic acid;
``(iii) the screening for and the treatment of
infections; and
``(iv) stress management;
``(D) treatments and outcomes for premature infants,
including late preterm infants;
``(E) the informational needs of families during the stay
of an infant in a neonatal intensive care unit; and
``(F) utilization of evidence-based strategies to prevent
birth injuries;''; and
(B) by striking paragraph (2) and inserting the following:
``(2) programs to increase the availability, awareness, and use
of pregnancy and post-term information services that provide
evidence-based, clinical information through counselors, community
outreach efforts, electronic or telephonic communication, or other
appropriate means regarding causes associated with prematurity,
birth defects, or health risks to a post-term infant;''; and
(2) in subsection (c), by striking ``$5,000,000'' and all that
follows through ``2011.'' and inserting ``$1,900,000 for each of
fiscal years 2014 through 2018.''.

990816f935d50dfc8dd527fbb248256f2762f1081d64fd792ea842d345e6d037

(a) Interagency Coordinating Council on Prematurity and Low
Birthweight.--The Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act is amended by striking section 5
(42 U.S.C. 247b-4g).
(b) Advisory Committee on Infant Mortality.--
(1) Establishment.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') may establish an
advisory committee known as the ``Advisory Committee on Infant
Mortality'' (referred to in this section as the ``Advisory
Committee'').
(2) Duties.--The Advisory Committee shall provide advice and
recommendations to the Secretary concerning the following
activities:
(A) Programs of the Department of Health and Human Services
that are directed at reducing infant mortality and improving
the health status of pregnant women and infants.
(B) Strategies to coordinate the various Federal programs
and activities with State, local, and private programs and
efforts that address factors that affect infant mortality.
(C) Implementation of the Healthy Start program under
section 330H of the Public Health Service Act (42 U.S.C. 254c-
8) and Healthy People 2020 infant mortality objectives.
(D) Strategies to reduce preterm birth rates through
research, programs, and education.
(3) Plan for hhs preterm birth activities.--Not later than 1
year after the date of enactment of this section, the Advisory
Committee (or an advisory committee in existence as of the date of
enactment of this Act and designated by the Secretary) shall
develop a plan for conducting and supporting research, education,
and programs on preterm birth through the Department of Health and
Human Services and shall periodically review and revise the plan,
as appropriate. The plan shall--
(A) examine research and educational activities that
receive Federal funding in order to enable the plan to provide
informed recommendations to reduce preterm birth and address
racial and ethnic disparities in preterm birth rates;
(B) identify research gaps and opportunities to implement
evidence-based strategies to reduce preterm birth rates among
the programs and activities of the Department of Health and
Human Services regarding preterm birth, including opportunities
to minimize duplication; and
(C) reflect input from a broad range of scientists,
patients, and advocacy groups, as appropriate.
(4) Membership.--The Secretary shall ensure that the membership
of the Advisory Committee includes the following:
(A) Representatives provided for in the original charter of
the Advisory Committee.
(B) A representative of the National Center for Health
Statistics.
(c) Patient Safety Studies and Report.--
(1) In general.--The Secretary shall designate an appropriate
agency within the Department of Health and Human Services to
coordinate existing studies on hospital readmissions of preterm
infants.
(2) Report to secretary and congress.--Not later than 1 year
after the date of the enactment of this Act, the agency designated
under paragraph (1) shall submit to the Secretary and to Congress a
report containing the findings and recommendations resulting from
the studies coordinated under such paragraph, including
recommendations for hospital discharge and followup procedures
designed to reduce rates of preventable hospital readmissions for
preterm infants.

2a6d05cbad479391809d57944f822104c4df72b4ec6db99d3eb32d2c327f5aa2

This title may be cited as the ``National Pediatric Research
Network Act of 2013''.

9b9fc53caf8908654a0fdd07f28125fe7e8e685b5b53df5bf3bb35ff567e332b

TITLE II

-NATIONAL PEDIATRIC RESEARCH NETWORK

Section 409D of the Public Health Service Act (42 U.S.C. 284h;
relating to the Pediatric Research Initiative) is amended--
(1) by redesignating subsection (d) as subsection (f); and
(2) by inserting after subsection (c) the following:
``(d) National Pediatric Research Network.--
``(1) Network.--In carrying out the Initiative, the Director of
NIH, in consultation with the Director of the Eunice Kennedy
Shriver National Institute of Child Health and Human Development
and in collaboration with other appropriate national research
institutes and national centers that carry out activities involving
pediatric research, may provide for the establishment of a National
Pediatric Research Network in order to more effectively support
pediatric research and optimize the use of Federal resources. Such
National Pediatric Research Network may be comprised of, as
appropriate--
``(A) the pediatric research consortia receiving awards
under paragraph (2); or
``(B) other consortia, centers, or networks focused on
pediatric research that are recognized by the Director of NIH
and established pursuant to the authorities vested in the
National Institutes of Health by other sections of this Act.
``(2) Pediatric research consortia.--
``(A) In general.--The Director of NIH may award funding,
including through grants, contracts, or other mechanisms, to
public or private nonprofit entities for providing support for
pediatric research consortia, including with respect to--
``(i) basic, clinical, behavioral, or translational
research to meet unmet needs for pediatric research; and
``(ii) training researchers in pediatric research
techniques in order to address unmet pediatric research
needs.
``(B) Research.--The Director of NIH shall, as appropriate,
ensure that--
``(i) each consortium receiving an award under
subparagraph (A) conducts or supports at least one category
of research described in subparagraph (A)(i) and
collectively such consortia conduct or support such
categories of research; and
``(ii) one or more such consortia provide training
described in subparagraph (A)(ii).
``(C) Organization of consortium.--Each consortium
receiving an award under subparagraph (A) shall--
``(i) be formed from a collaboration of cooperating
institutions;
``(ii) be coordinated by a lead institution or
institutions;
``(iii) agree to disseminate scientific findings,
including from clinical trials, rapidly and efficiently, as
appropriate, to--
``(I) other consortia;
``(II) the National Institutes of Health;
``(III) the Food and Drug Administration;
``(IV) and other relevant agencies; and
``(iv) meet such requirements as may be prescribed by
the Director of NIH.
``(D) Supplement, not supplant.--Any support received by a
consortium under subparagraph (A) shall be used to supplement,
and not supplant, other public or private support for
activities authorized to be supported under this paragraph.
``(E) Duration of support.--Support of a consortium under
subparagraph (A) may be for a period of not to exceed 5 years.
Such period may be extended at the discretion of the Director
of NIH.
``(3) Coordination of consortia activities.--The Director of
NIH shall, as appropriate--
``(A) provide for the coordination of activities (including
the exchange of information and regular communication) among
the consortia established pursuant to paragraph (2); and
``(B) require the periodic preparation and submission to
the Director of reports on the activities of each such
consortium.
``(4) Assistance with registries.--Each consortium receiving an
award under paragraph (2)(A) may provide assistance, as
appropriate, to the Centers for Disease Control and Prevention for
activities related to patient registries and other surveillance
systems upon request by the Director of the Centers for Disease
Control and Prevention.
``(e) Research on Pediatric Rare Diseases or Conditions.--In making
awards under subsection (d)(2) for pediatric research consortia, the
Director of NIH shall ensure that an appropriate number of such awards
are awarded to such consortia that agree to--
``(1) consider pediatric rare diseases or conditions, or those
related to birth defects; and
``(2) conduct or coordinate one or more multisite clinical
trials of therapies for, or approaches to, the prevention,
diagnosis, or treatment of one or more pediatric rare diseases or
conditions.''.

4cd26d598d6ba0a2b6638318bced5f833b4ba47b2d619d699733fab6b0578c70

This title may be cited as the ``CHIMP Act Amendments of 2013''.

0726471280a5089ed11aec73a191086c16b9e3e738e1e71777155ec88f88ea93

TITLE III

-CHIMP ACT AMENDMENTS

(a) In General.--Section 404K(g) of the Public Health Service Act
(42 U.S.C. 283m(g)) is amended--
(1) by amending paragraph (1) to read as follows:
``(1) In general.--Of the amount appropriated for the National
Institutes of Health, there are authorized to be appropriated to
carry out this section and for the care, maintenance, and
transportation of all chimpanzees otherwise under the ownership or
control of the National Institutes of Health, and to enable the
National Institutes of Health to operate more efficiently and
economically by decreasing the overall Federal cost of providing
for the care, maintenance, and transportation of chimpanzees--
``(A) for fiscal year 2014, $12,400,000;
``(B) for fiscal year 2015, $11,650,000;
``(C) for fiscal year 2016, $10,900,000;
``(D) for fiscal year 2017, $10,150,000; and
``(E) for fiscal year 2018, $9,400,000.'';
(2) by striking paragraph (2);
(3) by redesignating paragraph (3) as paragraph (2); and
(4) in paragraph (2), as so redesignated--
(A) by striking ``With respect to amounts reserved under
paragraph (1)'' and inserting ``With respect to amounts
authorized to be appropriated by paragraph (1)''; and
(B) by striking ``board of directors'' and inserting
``Secretary in consultation with the board of directors''.
(b) GAO Study.--Not later than 2 years after the date of enactment
of this Act, the Comptroller General of the United States shall conduct
an independent evaluation, and submit to the appropriate committees of
Congress a report, regarding chimpanzees under the ownership or control
the National Institutes of Health. Such report shall review and
assess--
(1) the research status of such chimpanzees;
(2) the cost for the care, maintenance, and transportation of
such chimpanzees, including the cost broken down by--
(A) research or retirement status;
(B) services included in the care, maintenance, and
transportation; and
(C) location;
(3) the extent to which matching requirements have been met
pursuant to section 404K(e)(4) of the Public Health Service Act (42
U.S.C. 283m(e)(4)); and
(4) any options for cost savings for the support and
maintenance of such chimpanzees.
(c) Biennial Report.--Section 404K(g) of the Public Health Service
Act (42 U.S.C. 283m(g)) is amended by adding at the end the following:
``(3) Biennial report.--Not later than 180 days after the date
enactment of this Act, the Director of the National Institutes of
Health shall submit to the Committee on Health, Education, Labor,
and Pensions and the Committee on Appropriations of the Senate and
the Committee on Energy and Commerce and the Committee on
Appropriations in the House of Representatives a report, to be
updated biennially, regarding--
``(A) the care, maintenance, and transportation of the
chimpanzees under the ownership or control of the National
Institutes of Health;
``(B) costs related to such care, maintenance, and
transportation, and any other related costs; and
``(C) the research status of such chimpanzees.''.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.

fa8f11a8d73d4bf55341203685b8b376dfd35f38dde1d3fedc9b19fde5e98710

PREEMIE Reauthorization Act — S. 252

Other Sections

TITLE I

TITLE II

TITLE III

Want the full experience?